CSF2 and myeloid sarcoma: Cytometric analysis revealed a significant increase in GM-CSF levels, a cytokine linked to inflammation in MS (37), produced by CD8+ T-cells after exposure to pHERV-Wenv 486–504 in RR-SMS and PP-MS patients.